200 related articles for article (PubMed ID: 29439835)
21. Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.
Zerif E; Maalem A; Gaudreau S; Guindi C; Ramzan M; Véroneau S; Gris D; Stankova J; Rola-Pleszczynski M; Mourad W; Dupuis G; Amrani A
J Autoimmun; 2017 Jan; 76():63-74. PubMed ID: 27634616
[TBL] [Abstract][Full Text] [Related]
22. Revealing the specificity of regulatory T cells in murine autoimmune diabetes.
Spence A; Purtha W; Tam J; Dong S; Kim Y; Ju CH; Sterling T; Nakayama M; Robinson WH; Bluestone JA; Anderson MS; Tang Q
Proc Natl Acad Sci U S A; 2018 May; 115(20):5265-5270. PubMed ID: 29712852
[TBL] [Abstract][Full Text] [Related]
23. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity.
Tran GT; Hodgkinson SJ; Carter NM; Verma ND; Plain KM; Boyd R; Robinson CM; Nomura M; Killingsworth M; Hall BM
Blood; 2012 May; 119(19):4441-50. PubMed ID: 22310911
[TBL] [Abstract][Full Text] [Related]
24. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
[TBL] [Abstract][Full Text] [Related]
25. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
26. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
27. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.
Yin B; Ma G; Yen CY; Zhou Z; Wang GX; Divino CM; Casares S; Chen SH; Yang WC; Pan PY
J Immunol; 2010 Nov; 185(10):5828-34. PubMed ID: 20956337
[TBL] [Abstract][Full Text] [Related]
28. Targeted delivery of antigen to intestinal dendritic cells induces oral tolerance and prevents autoimmune diabetes in NOD mice.
Chen Y; Wu J; Wang J; Zhang W; Xu B; Xu X; Zong L
Diabetologia; 2018 Jun; 61(6):1384-1396. PubMed ID: 29546475
[TBL] [Abstract][Full Text] [Related]
29. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
30. Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo.
Radhakrishnan S; Cabrera R; Schenk EL; Nava-Parada P; Bell MP; Van Keulen VP; Marler RJ; Felts SJ; Pease LR
J Immunol; 2008 Sep; 181(5):3137-47. PubMed ID: 18713984
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype
Brusko MA; Stewart JM; Posgai AL; Wasserfall CH; Atkinson MA; Brusko TM; Keselowsky BG
Front Immunol; 2020; 11():574447. PubMed ID: 33193362
[TBL] [Abstract][Full Text] [Related]
32. Both central and peripheral tolerance mechanisms play roles in diabetes prevention in NOD-E transgenic mice.
Mellanby RJ; Phillips JM; Parish NM; Cooke A
Autoimmunity; 2008 Aug; 41(5):383-94. PubMed ID: 18568644
[TBL] [Abstract][Full Text] [Related]
33. Targeting DEC-205
Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
[TBL] [Abstract][Full Text] [Related]
34. PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes.
Graham JG; Zhang X; Goodman A; Pothoven K; Houlihan J; Wang S; Gower RM; Luo X; Shea LD
Tissue Eng Part A; 2013 Jun; 19(11-12):1465-75. PubMed ID: 23432371
[TBL] [Abstract][Full Text] [Related]
35. Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.
Morlacchi S; Soldani C; Viola A; Sarukhan A
Blood; 2011 Jul; 118(4):984-91. PubMed ID: 21652680
[TBL] [Abstract][Full Text] [Related]
36. Tumor-derived CD4+CD25+ Tregs inhibit the maturation and antigen-presenting function of dendritic cells.
Du Y; Chen X; Lin XQ; Wu W; Huang ZM
Asian Pac J Cancer Prev; 2015; 16(7):2665-9. PubMed ID: 25854343
[TBL] [Abstract][Full Text] [Related]
37. The interactions of dendritic cells with antigen-specific, regulatory T cells that suppress autoimmunity.
Tarbell KV; Yamazaki S; Steinman RM
Semin Immunol; 2006 Apr; 18(2):93-102. PubMed ID: 16469503
[TBL] [Abstract][Full Text] [Related]
38. Rapamycin combined with allogenic immature dendritic cells selectively expands CD4+CD25+Foxp3+ regulatory T cells in rats.
Wang GY; Zhang Q; Yang Y; Chen WJ; Liu W; Jiang N; Chen GH
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):203-8. PubMed ID: 22484590
[TBL] [Abstract][Full Text] [Related]
39. Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
Vazquez-Mateo C; Collins J; Goldberg SJ; Lawson M; Hernandez-Escalante J; Dooms H
PLoS One; 2019; 14(3):e0214379. PubMed ID: 30908554
[TBL] [Abstract][Full Text] [Related]
40. IL-2/CD25: A Long-Acting Fusion Protein That Promotes Immune Tolerance by Selectively Targeting the IL-2 Receptor on Regulatory T Cells.
Ward NC; Yu A; Moro A; Ban Y; Chen X; Hsiung S; Keegan J; Arbanas JM; Loubeau M; Thankappan A; Yamniuk AP; Davis JH; Struthers M; Malek TR
J Immunol; 2018 Nov; 201(9):2579-2592. PubMed ID: 30282751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
